Seattle Genetics, Inc. (NASDAQ:SGEN)

CAPS Rating: 3 out of 5

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.

Recs

0
Player Avatar Wiseinvest70 (56.57) Submitted: 9/17/2010 7:02:53 PM : Outperform Start Price: $12.00 SGEN Score: +54.39

This is another pick similar to the one I did from HGSI, I have been reviewing the info for this company and it really is a must buy company. They are extremely close to become a CASH COW, I would not be surprise to see their stock in the range of 150 Dlls in the next 2 years.

Report this Post Reply

Featured Broker Partners


Advertisement